SE435177B - Nya halogenderivat av 2-isopropylamino-pyrimidin och forfarande for framstellning derav - Google Patents
Nya halogenderivat av 2-isopropylamino-pyrimidin och forfarande for framstellning deravInfo
- Publication number
- SE435177B SE435177B SE8003241A SE8003241A SE435177B SE 435177 B SE435177 B SE 435177B SE 8003241 A SE8003241 A SE 8003241A SE 8003241 A SE8003241 A SE 8003241A SE 435177 B SE435177 B SE 435177B
- Authority
- SE
- Sweden
- Prior art keywords
- isopropylamino
- pyrimidine
- preparing
- fluorine
- procedures
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 3
- 229910052736 halogen Inorganic materials 0.000 title claims 2
- -1 HALOGEN DERIVATIVES OF 2-ISOPROPYLAMINO-PYRIMIDINE Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 15
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 6
- 235000003270 potassium fluoride Nutrition 0.000 claims description 3
- 239000011698 potassium fluoride Substances 0.000 claims description 3
- ZJQAKBVJJMKLEX-UHFFFAOYSA-N 5-bromo-n-propan-2-ylpyrimidin-2-amine Chemical group CC(C)NC1=NC=C(Br)C=N1 ZJQAKBVJJMKLEX-UHFFFAOYSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- 229910052731 fluorine Inorganic materials 0.000 claims 4
- 239000011737 fluorine Substances 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 239000000460 chlorine Chemical group 0.000 claims 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 2
- FTCYIGBVOHNHCD-UHFFFAOYSA-N isaxonine Chemical compound CC(C)NC1=NC=CC=N1 FTCYIGBVOHNHCD-UHFFFAOYSA-N 0.000 claims 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 229960002317 succinimide Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 238000007912 intraperitoneal administration Methods 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 210000003497 sciatic nerve Anatomy 0.000 description 3
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- XBTFODSSIVKQTO-UHFFFAOYSA-N 5-fluoro-n-propan-2-ylpyrimidin-2-amine Chemical compound CC(C)NC1=NC=C(F)C=N1 XBTFODSSIVKQTO-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7916918 | 1979-05-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8003241L SE8003241L (sv) | 1980-11-16 |
| SE435177B true SE435177B (sv) | 1984-09-10 |
Family
ID=10505180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8003241A SE435177B (sv) | 1979-05-15 | 1980-04-29 | Nya halogenderivat av 2-isopropylamino-pyrimidin och forfarande for framstellning derav |
Country Status (30)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE894517A (fr) * | 1981-10-16 | 1983-01-17 | Sod Conseils Rech Applic | Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes |
| US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
| US4868161A (en) * | 1984-06-29 | 1989-09-19 | City Of Hope | Method for promoting nerve regeneration |
| HU206337B (en) * | 1988-12-29 | 1992-10-28 | Mitsui Petrochemical Ind | Process for producing pyrimidine derivatives and pharmaceutical compositions |
| US5264435A (en) * | 1988-12-29 | 1993-11-23 | Mitsui Petrochemical Industries, Ltd. | Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2436360A (en) * | 1948-02-17 | Preparation of z-amino-s-chloro | ||
| US2609372A (en) * | 1950-05-05 | 1952-09-02 | Sharp & Dohme Inc | Halogenation of 2-aminopyrimidines |
| US3984414A (en) * | 1971-10-09 | 1976-10-05 | Societe D'etudes De Produits Chimiques | Dichloroacetate salt of 2-isopropylamino pyrimidine |
| BE788648A (fr) * | 1971-10-09 | 1973-01-02 | Soc D Etudes Prod Chimique | Derives de l'isopropylamino pyrimidine, leur preparation leur composition et leur utilisation therapeutique |
| GB1525995A (en) * | 1976-02-18 | 1978-09-27 | Soc D Etudes Prod Chimique | Aminopyrimidine salt |
-
1980
- 1980-04-17 BE BE0/200269A patent/BE882836A/fr not_active IP Right Cessation
- 1980-04-18 CH CH301680A patent/CH645103A5/fr not_active IP Right Cessation
- 1980-04-21 ZA ZA00802375A patent/ZA802375B/xx unknown
- 1980-04-22 IN IN289/DEL/80A patent/IN154370B/en unknown
- 1980-04-22 LU LU82379A patent/LU82379A1/fr unknown
- 1980-04-22 MA MA19020A patent/MA18825A1/fr unknown
- 1980-04-24 AT AT0221480A patent/AT375074B/de active
- 1980-04-24 AU AU57790/80A patent/AU529581B2/en not_active Ceased
- 1980-04-24 FI FI801330A patent/FI68045C/fi not_active IP Right Cessation
- 1980-04-24 IT IT21641/80A patent/IT1148798B/it active
- 1980-04-25 NL NL8002421A patent/NL8002421A/nl not_active Application Discontinuation
- 1980-04-25 MX MX808778U patent/MX6295E/es unknown
- 1980-04-28 NZ NZ193533A patent/NZ193533A/xx unknown
- 1980-04-28 US US06/144,761 patent/US4267181A/en not_active Expired - Lifetime
- 1980-04-28 AR AR280827A patent/AR222872A1/es active
- 1980-04-28 IE IE862/80A patent/IE49708B1/en unknown
- 1980-04-28 NO NO801236A patent/NO154057C/no unknown
- 1980-04-28 JP JP5557680A patent/JPS55151571A/ja active Granted
- 1980-04-29 EG EG259/80A patent/EG14260A/xx active
- 1980-04-29 SE SE8003241A patent/SE435177B/sv not_active IP Right Cessation
- 1980-04-29 ES ES491004A patent/ES8104252A1/es not_active Expired
- 1980-04-29 PT PT71162A patent/PT71162A/pt unknown
- 1980-04-29 DK DK183980A patent/DK183980A/da unknown
- 1980-04-29 DE DE3016549A patent/DE3016549C2/de not_active Expired
- 1980-04-30 OA OA57102A patent/OA06526A/xx unknown
- 1980-04-30 FR FR8009731A patent/FR2456734A1/fr active Granted
- 1980-04-30 FR FR8009730A patent/FR2456521A1/fr active Granted
- 1980-04-30 CA CA350,989A patent/CA1132562A/en not_active Expired
-
1983
- 1983-04-28 SG SG224/83A patent/SG22483G/en unknown
- 1983-11-17 HK HK554/83A patent/HK55483A/xx unknown
-
1984
- 1984-12-30 MY MY201/84A patent/MY8400201A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1408984B1 (de) | Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen | |
| DE69110254T2 (de) | Hydroxychinolonderivate. | |
| KR101793777B1 (ko) | 만성 폐쇄성 폐 질환의 급성 악화의 치료에서의 피라졸 유도체의 용도 | |
| CN107249591A (zh) | 治疗癌症的方法 | |
| DE69429147T2 (de) | Benzamidderivate | |
| SE435177B (sv) | Nya halogenderivat av 2-isopropylamino-pyrimidin och forfarande for framstellning derav | |
| SE502923C2 (sv) | Användning av en polyprenylförening för framställning av protylaktiskt/terapeutiskt medel för humana och animala sjukdomar beroende på bristfälligt immunförsvar | |
| DE1949813C3 (de) | 3-<4-Pvridyl)-4-(2-hydroxvphenyl)-5-alkyl-pyrazole | |
| JPS6126996B2 (cg-RX-API-DMAC7.html) | ||
| US3993767A (en) | Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy | |
| CN1034922A (zh) | 新四氢吡啶衍生物制备方法 | |
| NL8002272A (nl) | Werkwijze ter bereiding van isopropylaminopyrimidine- hydroxy-derivaten. | |
| US3560619A (en) | Aminoquinazolines and quinazolones in treatment of coccidiosis | |
| RU2208014C2 (ru) | ПРОИЗВОДНЫЕ 1,3-ДИОКСОЛ/4,5-h//2,3/БЕНЗОДИАЗЕПИНА, ЯВЛЯЮЩИЕСЯ ИНГИБИТОРАМИ AMPA/КАИНАТНОГО РЕЦЕПТОРА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБ ЛЕЧЕНИЯ | |
| US4393081A (en) | Methyl 3-acetamido-2-(5-methoxy-indol-3-yl) propanoate and hypotensive use thereof | |
| SE440651B (sv) | Sett att framstella piperidyl-indol-derivat och farmaceutiska kompositioner innehallande vissa av dessa foreningar | |
| DE69615845T2 (de) | Polycyclische alkaloid-derivate als nmda-rezeptor-antagonisten | |
| JP2520620B2 (ja) | 発癌プロモ−タ−抑制剤 | |
| EP0254068B1 (en) | Novel therapeutic agent for gastritis | |
| RU2665037C2 (ru) | Изопропил N-[{ [(1R)-2-(6-амино-9H-пурин-9-ил)-1-метилэтокси]метил} (1,3-бензотиазол-6-ил-окси)фосфорил]-L-аланинат фумарат в качестве противовирусного препарата - пролекарства Тенофовира | |
| JPS63208519A (ja) | 発癌促進物質抑制剤 | |
| SE446865B (sv) | Nya derivat av 1,3-bensoxazin-2,4-dion, forfarande for framstellning derav samt farmaceutiska kompositioner | |
| HU206625B (en) | Process for producing pharmaceutical composition containing pharmaceutically active organosilane derivatives | |
| JP3112356B2 (ja) | シクロペンテノン化合物及び該化合物を有効成分とする脳機能改善薬 | |
| JPS61210092A (ja) | ジヒドロピリジン−５−ホスホン酸ジアミド誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8003241-0 Effective date: 19910117 Format of ref document f/p: F |